Literature DB >> 12711024

Tamoxifen administration and metabolism in nude mice and nude rats.

E R Kisanga1, J Gjerde, J Schjøtt, G Mellgren, E A Lien.   

Abstract

We investigated the kinetics of tamoxifen (tam) in immunodeficient mice and rats after oral treatment and compared drug and metabolite profile in nude rat serum and tissues after oral and subcutaneous (s.c.) routes of administration. The serum levels were compared to those observed in man. After oral dosing in mice, tam and the potent metabolite 4-hydroxytamoxifen (4-hydroxytam), were detectable in liver and lung tissue, but not in serum. The levels of 4-hydroxytam in these tissues were significantly higher than those of tam, a profile opposite to that observed in rat and man. In rats and man, the 4-hydroxytam/tam serum concentration ratios were 0.16 and 0.02, respectively. Compared to oral route, the s.c. pellets yielded only trace amounts of the demethylated derivatives of tam in rats. Thus, the kinetics of tam observed in the present study suggest that the nude rat may represent a preferable animal model in studying the pharmacokinetics of tam and that, the oral route yielded higher serum and tissue levels of tam and metabolites than equivalent s.c. pellet implants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711024     DOI: 10.1016/s0960-0760(03)00051-7

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  14 in total

Review 1.  Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Authors:  Sarah Mikelman; Natalie Mardirossian; Margaret E Gnegy
Journal:  J Chem Neuroanat       Date:  2016-08-30       Impact factor: 3.052

2.  The cancer drug tamoxifen: a potential therapeutic treatment for spinal cord injury.

Authors:  Jutatip Guptarak; John E Wiktorowicz; Rovshan G Sadygov; Dragoslava Zivadinovic; Adriana A Paulucci-Holthauzen; Leoncio Vergara; Olivera Nesic
Journal:  J Neurotrauma       Date:  2013-12-11       Impact factor: 5.269

3.  Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice.

Authors:  Ellen A Walker; John J Foley; Rachel Clark-Vetri; Robert B Raffa
Journal:  Psychopharmacology (Berl)       Date:  2011-05-03       Impact factor: 4.530

4.  Targeting tamoxifen to breast cancer xenograft tumours: preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide-bond-reduced albumin.

Authors:  A Martínez; E Muñiz; C Teijón; I Iglesias; J M Teijón; M D Blanco
Journal:  Pharm Res       Date:  2013-11-12       Impact factor: 4.200

5.  Tamoxifen Directly Interacts with the Dopamine Transporter.

Authors:  Sarah R Mikelman; Bipasha Guptaroy; Kyle C Schmitt; Kymry T Jones; Juan Zhen; Maarten E A Reith; Margaret E Gnegy
Journal:  J Pharmacol Exp Ther       Date:  2018-08-14       Impact factor: 4.030

6.  Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.

Authors:  Line L Haugan Moi; Marianne Hauglid Flågeng; Jennifer Gjerde; Andre Madsen; Therese Halvorsen Røst; Oddrun Anita Gudbrandsen; Ernst A Lien; Gunnar Mellgren
Journal:  BMC Cancer       Date:  2012-06-15       Impact factor: 4.430

7.  Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials.

Authors:  Shunchao Yan; Kai Li; Xin Jiao; Huawei Zou
Journal:  Onco Targets Ther       Date:  2015-06-12       Impact factor: 4.147

8.  Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling.

Authors:  Michelle L Asp; Joshua J Martindale; Joseph M Metzger
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

9.  The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton.

Authors:  Anne Gingery; Malayannan Subramaniam; Kevin S Pitel; Jordan M Reese; Muzaffer Cicek; Laurence B Lindenmaier; James N Ingle; Matthew P Goetz; Russell T Turner; Urszula T Iwaniec; Thomas C Spelsberg; John R Hawse
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

10.  Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions.

Authors:  Madryn C Lake; Quang-Dé Nguyen; Simak Ali; Eric O Aboagye
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.